Trial intelligence / Profile preview

Notuss syrup for cough and rhinitis in children

NCT01177852Phase 3Withdrawn

Sponsor
Aché Laboratórios Farmacêuticos
Start
Oct 2011
Primary completion
Apr 2012
Modality
Small Molecules
01

Overview

Phase 3, randomised, open-label trial of Notuss in cough and acute rhinitis (2 arms), sponsored by Aché Laboratórios Farmacêuticos. Primary endpoint: Improvement of nasal congestion and cough at 2 days. Planned start Oct 2011; status: withdrawn.

02

Drugs

Notuss
03

Conditions

coughacute rhinitis

Beyond the preview

Go deeper on NCT01177852.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01177852.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call